Norah Terrault, MD
Enriched profileProfessor of Medicine; Chief of Gastroenterology and Liver Diseases; Neil Kaplowitz Endowed Chair in Liver Diseases Research · Keck School of Medicine of USC
Norah Terrault is Professor of Medicine; Chief of Gastroenterology and Liver Diseases; Neil Kaplowitz Endowed Chair in Liver Diseases Research at Keck School of Medicine of USC. OpenAlex indexes 747 publications with 48,598 citations (h-index 107); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 8 Oct 2026
Overview
Updated 12 Oct 2026
Norah Terrault, MD, is Professor of Medicine at Keck School of Medicine of USC. The public record shows 747 publications with 48,598 citations (h-index 107), centered on Hepatitis C virus research, Organ Transplantation Techniques and Outcomes, Hepatitis B Virus Studies. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 9 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Liver transplantation
- Top research focus: Hepatitis C virus research
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 71 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 398.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →keck.usc.edu ↗
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 12 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Sponsor: Biotest Pharmaceuticals Corporation
Industry payments
Updated 12 Oct 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20241 payment
- Gilead Sciences, Inc.Program year20221 payment
NIH funding
Updated 12 Oct 2026
9 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
University of Southern California
FY2026$765,068R01MD015971 - 1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
University of Southern California
FY2026$577,500R01AA030960
Congress activity
Updated 12 Oct 2026
1 congress contribution (2015) across AMCP per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 12 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A pilot randomized controlled trial of a transportation assistance program in liver transplant (TAP-LT) candidates.
Liver transplantation
Clinical Trial2026 - AASLD ISDA Practice Guideline on treatment of chronic hepatitis B.
Hepatology (Baltimore, Md.)
Guideline2026 - Reframing hepatitis B prophylaxis in recipients of liver transplant: Time to focus on cure.
Liver transplantation
Article2026 - The Obstacle is the Way: Finding a Path to Hepatitis C Elimination.
Clinical infectious diseases
Article2026
Most-cited works
by citation count (OpenAlex)- 01Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceArticle4,400 citations2018
- 02
- 03AASLD guidelines for treatment of chronic hepatitis BArticle2,034 citations2015
- 04Global epidemiology of cirrhosis — aetiology, trends and predictionsReview851 citations2023
- 05
Network
Updated 12 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 12 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
aasld.org/liver-fellow-network/core-series/podcast/all-things-liver-norah-terrault
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 12 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Alberta (fellowships in internal medicine and gastroenterology, University of Toronto)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →keck.usc.edu ↗ - MPH
University of California, Berkeley
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →keck.usc.edu ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aasld.org ↗
- Associate Editor
Hepatology Communications
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗ - Member
AASLD HCV Guidance Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
John Ringman, MD
Keck School of Medicine of USC
Leslie Saxon, MD
Keck School of Medicine of USC
William Stohl, MD
Keck School of Medicine of USC
Nerses Sanossian, MD
Keck School of Medicine of USC
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic